Amolyt Pharma to Present Preliminary Phase 1 Data on AZP-3601 for Hypoparathyroidism and Additional Preclinical Data on AZP-3404 at ENDO 2021

NEXT STORY
Vaccinex Reports Fourth Quarter 2020 Financial Results and Provides Corporate Update
PREV STORY
Blood Cell Separation Market 2021 | Market Size, Share, Growth, Trends, Competitive Landscape, Revenue, Forecast Report 2021-2028
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Nanfang Hospital Receives 2019 Clinical PDT Research Excellence Award at the 17th World Congress of the International Photodynamic Association in Boston

author_avatar
NASDAQ Market News

Cytovia Therapeutics and the University of California, San Francisco enter into a partnership to develop precision gene-edited CAR-NK cell therapy

author_avatar
NASDAQ Market News

TG Therapeutics Announces Data from a Phase 1 Study Evaluating TG-1701 as a Monotherapy and as a Triple Combination with Ublituximab and UKONIQ® at the 2021 European Hematology Association Virtual Congress

author_avatar
NASDAQ Market News